Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411

Area of Science:

• Molecular Biology
• Cancer Research
• Drug Discovery

Background:

• AS1411 is a DNA aptamer known for its antiproliferative properties.
• Nucleolin is a ubiquitous protein that AS1411 binds to.
• Understanding the interaction between AS1411 and nucleolin is crucial for its therapeutic potential.

Purpose of the Study:

• To investigate the effect of nucleolin overexpression on cellular sensitivity to AS1411.
• To elucidate the implications of this interaction for the clinical application of AS1411.

Main Methods:

• HeLa cells were engineered to constitutively overexpress nucleolin.
• Cell growth, invasiveness, apoptosis, and cell cycle progression were analyzed.
• AS1411 treatment was administered to both overexpressing and control cells.

Main Results:

• Nucleolin-overexpressing HeLa cells exhibited increased growth rate and invasiveness.
• These cells showed heightened sensitivity to AS1411, with increased growth inhibition.
• AS1411 treatment led to increased apoptosis and cell cycle arrest in nucleolin-overexpressing cells.
• AS1411 was found to induce nucleolin expression at both RNA and protein levels.

Conclusions:

• Constitutive nucleolin overexpression sensitizes cells to AS1411's growth inhibitory effects.
• A feedback loop exists where AS1411 induces nucleolin expression, impacting its own efficacy.
• These findings have significant implications for the clinical use of AS1411 in cancer therapy.